We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $80.16 · 32 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Boston Scientific Corp (NYSE:BSX): A Decent Value Play with Strong Fundamentals and an Attractive Valuation - ChartMill
Boston Scientific Corp (NYSE:BSX): A Decent Value Play with Strong Fundamentals and an Attractive Valuation ChartMill
Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition - Yahoo Finance
Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition Yahoo Finance
Boston Scientific Stock Hits Key Support – Buying Opportunity? - Trefis
Boston Scientific Stock Hits Key Support – Buying Opportunity? Trefis
Boston Scientific Stock Near Crucial Support - Buy Signal? - Trefis
Boston Scientific Stock Near Crucial Support - Buy Signal? Trefis
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific Corp. stock underperforms Friday when compared to competitors MarketWatch
UBS (AMUB) launches autocallable notes tied to Boston Scientific (due 06/02/2027) - Stock Titan
UBS (AMUB) launches autocallable notes tied to Boston Scientific (due 06/02/2027) Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 29. | After market close (AMC) | $0.83 | — | — | $5.38B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.45 | — | — | $4.66B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $0.87 | — | — | $12.19B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $0.55 | — | — | $7.98B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 29. | Wolfe Research | — | Downgrade | Outperform → Peer Perform | — | Wolfe Research: Outperform → Peer Perform |
| 2026. 05. 29. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 05. 29. | Leerink Partners | — | Maintain | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 05. 28. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 28. | Wells Fargo | — | Downgrade | Overweight → Equal-Weight | — | Wells Fargo: Overweight → Equal-Weight |
| 2026. 05. 19. | Baird | — | Maintain | Outperform → Outperform | — | Baird: Outperform |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 9,411,231 | $590.55B | 0.50% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 2,471,344 | $235.64B | 0.37% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 2,434,563 | $232.14B | 0.38% | — | New position |
| 4 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 3,687,315 | $231.38B | 0.42% | — | New position |